Work

Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy

Year: 2024

Type: article

Study design: Observational Study

Source: American Journal of Clinical Oncology

DOI: 10.1097/coc.0000000000001087

Authors: Zakaria Chakrani, George Mellgard, Nathaniel Saffran, Stephen McCroskery, Nicole Taylor, Mann Patel, Bobby Liaw, Matthew Galsky, William K. Oh, Che-Kai Tsao, Vaibhav G. Patel

Institutions: Icahn School of Medicine at Mount Sinai, Columbia University Irving Medical Center, Tisch Cancer Institute, Rutgers New Jersey Medical School, Prostate Cancer Foundation, Arvinas (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4391747554

FWCI: 1.034

Cites: 30

Cited by: 4

Related to: 10